A-HeFT
Franciosa JA, Taylor AL, Cohn JN, Yancy CW, Ziesche S, Olukotun A, Ofili E,
Ferdinand K, Loscalzo J, Worcel M; A-HeFT Investigators.
African-American Heart Failure Trial (A-HeFT): rationale, design, and
methodology.
J Card Fail. 2002 Jun;8(3):128-35.
PMID: 12140804 [PubMed - indexed for MEDLINE] |
ACORN
Mann DL, Acker MA, Jessup M, Sabbah HN, Starling RC, Kubo SH; Acorn
Investigators and Study Coordinators.
Rationale, design, and methods for a pivotal randomized clinical trial for the assessment of a cardiac support device in patients with New York health association class III-IV heart failure.
J Card Fail. 2004 Jun;10(3):185-92.
PMID: 15190527 [PubMed - indexed for MEDLINE] |
ACTIV in CHF
Gheorghiade M, Gattis WA, O'Connor CM, Adams KF Jr, Elkayam U, Barbagelata
A, Ghali JK, Benza RL, McGrew FA, Klapholz M, Ouyang J, Orlandi C;
Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Congestive Heart
Failure (ACTIV in CHF) Investigators.
Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial.
JAMA. 2004 Apr 28;291(16):1963-71.
PMID: 15113814 [PubMed - indexed for MEDLINE] |
AIRE
[No authors listed]
Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators.
Lancet. 1993 Oct 2;342(8875):821-8.
PMID: 8104270 [PubMed - indexed for MEDLINE] |
AMIOVIRT
Strickberger SA, Hummel JD, Bartlett TG, Frumin HI, Schuger CD, Beau SL, Bitar C, Morady F; AMIOVIRT Investigators.
Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia--AMIOVIRT.
J Am Coll Cardiol. 2003 May 21;41(10):1707-12.
PMID: 12767651 [PubMed - indexed for MEDLINE] |
ANZ
[No authors listed]
Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart
Failure Research Collaborative Group.
Lancet. 1997 Feb 8;349(9049):375-80.
PMID: 9033462 [PubMed - indexed for MEDLINE] |
ATLAS
Packer M, Poole-Wilson PA, Armstrong PW, Cleland JG, Horowitz JD, Massie BM, Ryden L, Thygesen K, Uretsky BF.
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.
Circulation. 1999 Dec 7;100(23):2312-8.
PMID: 10587334 [PubMed - indexed for MEDLINE] |
ATTACH
Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT; Anti-TNF Therapy Against Congestive Heart Failure Investigators.
Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial.
Circulation. 2003 Jul 1;107(25):3133-40. Epub 2003 Jun 9.
PMID: 12796126 [PubMed - indexed for MEDLINE] |
BASEL
Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P, Pfisterer M, Perruchoud AP.
Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.
N Engl J Med. 2004 Feb 12;350(7):647-54.
PMID: 14960741 [PubMed - indexed for MEDLINE] |
Beneficial effects of ramipril on left ventricular end-diastolic and end-systolic volume indexes
Kjoller-Hansen L, Steffensen R, Grande P.
Beneficial effects of ramipril on left ventricular end-diastolic and end-systolic volume indexes after uncomplicated invasive revascularization are associated with a reduction in cardiac events in patients with moderately impaired left ventricular function and no clinical heart failure.
J Am Coll Cardiol. 2001 Apr;37(5):1214-20.
PMID: 11300425 [PubMed - indexed for MEDLINE] |
BEST
Anderson JL, Krause-Steinrauf H, Goldman S, Clemson BS, Domanski MJ, Hager WD, Murray DR, Mann DL, Massie BM, McNamara DM, Oren R, Rogers WJ;
Beta-Blocker Evaluation of Survival Trial (BEST) Investigators.
Failure of benefit and early hazard of bucindolol for Class IV heart failure.
J Card Fail. 2003 Aug;9(4):266-77.
PMID: 13680547 [PubMed - indexed for MEDLINE] |
BNP
Wright SP, Doughty RN, Pearl A, Gamble GD, Whalley GA, Walsh HJ, Gordon G, Bagg W, Oxenham H, Yandle T, Richards M, Sharpe N.
Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial.
J Am Coll Cardiol. 2003 Nov 19;42(10):1793-800.
PMID: 14642690 [PubMed - indexed for MEDLINE] |
Bucindolol in patients with advanced chronic heart failure Beta-Blocker Evaluation of Survival Trial Investigators.
A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure.
N Engl J Med. 2001 May 31;344(22):1659-67.
PMID: 11386264 [PubMed - indexed for MEDLINE] |
CANPAP
Bradley TD, Logan AG, Kimoff RJ, Series F, Morrison D, Ferguson K, Belenkie I, Pfeifer M, Fleetham J, Hanly P, Smilovitch M, Tomlinson G, Floras JS; CANPAP Investigators.
Continuous positive airway pressure for central sleep apnea and heart failure.
N Engl J Med. 2005 Nov 10;353(19):2025-33.
PMID: 16282177 [PubMed - indexed for MEDLINE] |
Cardiac resynchronization therapy for the treatment of heart failure
Higgins SL, Hummel JD, Niazi IK, Giudici MC, Worley SJ, Saxon LA, Boehmer JP, Higginbotham MB, De Marco T, Foster E, Yong PG.
Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias.
J Am Coll Cardiol. 2003 Oct 15;42(8):1454-9.
PMID: 14563591 [PubMed - indexed for MEDLINE] |
CAPRICORN
Dargie HJ.
Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial.
Lancet. 2001 May 5;357(9266):1385-90.
PMID: 11356434 [PubMed - indexed for MEDLINE] |
CARE-HF
Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L; Cardiac Resynchronization-Heart Failure (CARE-HF) Study
Investigators.
The effect of cardiac resynchronization on morbidity and mortality in heart failure.
N Engl J Med. 2005 Apr 14;352(15):1539-49. Epub 2005 Mar 7.
PMID: 15753115 [PubMed - indexed for MEDLINE] |
CARMEN
Remme WJ, Riegger G, Hildebrandt P, Komajda M, Jaarsma W, Bobbio M, Soler-Soler J, Scherhag A, Lutiger B, Ryden L.
The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN).
Cardiovasc Drugs Ther. 2004 Jan;18(1):57-66.
PMID: 15115904 [PubMed - indexed for MEDLINE] |
CARVEDILOL
Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH.
The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.
N Engl J Med. 1996 May 23;334(21):1349-55.
PMID: 8614419 [PubMed - indexed for MEDLINE] |
Carvedilol for dilated cardiomyopathy in dialysis patients
Cice G, Ferrara L, Di Benedetto A, Russo PE, Marinelli G, Pavese F, Iacono A.
Dilated cardiomyopathy in dialysis patients--beneficial effects of carvedilol: a double-blind, placebo-controlled trial.
J Am Coll Cardiol. 2001 Feb;37(2):407-11.
PMID: 11216954 [PubMed - indexed for MEDLINE] |
CAT
Bansch D, Antz M, Boczor S, Volkmer M, Tebbenjohanns J, Seidl K, Block M, Gietzen F, Berger J, Kuck KH.
Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT).
Circulation. 2002 Mar 26;105(12):1453-8.
PMID: 11914254 [PubMed - indexed for MEDLINE] |
CHARM-Added-trial
McMurray JJ, Ostergren J, Swedberg K, Granger CB, Held P, Michelson EL, Olofsson B, Yusuf S, Pfeffer MA; CHARM Investigators and Committees.
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.
Lancet. 2003 Sep 6;362(9386):767-71.
PMID: 13678869 [PubMed - indexed for MEDLINE] |
CHARM-Alternative-trial
Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B, Ostergren J, Pfeffer MA, Swedberg K; CHARM Investigators and Committees.
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.
Lancet. 2003 Sep 6;362(9386):772-6.
PMID: 13678870 [PubMed - indexed for MEDLINE] |
CHARM-OVERALL Programme Results
Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, Yusuf S, Pocock S; CHARM Investigators and Committees.
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme.
Lancet. 2003 Sep 6;362(9386):759-66.
PMID: 13678868 [PubMed - indexed for MEDLINE] |
CHARM-PRESERVED
Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J; CHARM Investigators and Committees.
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial.
Lancet. 2003 Sep 6;362(9386):777-81.
PMID: 13678871 [PubMed - indexed for MEDLINE] |
CHF-STAT
Massie BM, Fisher SG, Radford M, Deedwania PC, Singh BN, Fletcher RD, Singh SN.
Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. CHF-STAT Investigators.
Circulation. 1996 Jun 15;93(12):2128-34. Erratum in: Circulation 1996 Nov
15;94 10):2668.
PMID: 8925581 [PubMed - indexed for MEDLINE] |
CHRISTMAS
Cleland JG, Pennell DJ, Ray SG, Coats AJ, Macfarlane PW, Murray GD, Mule JD, Vered Z, Lahiri A; Carvedilol hibernating reversible ischaemia trial: marker of success investigators.
Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomized controlled trial.
Lancet. 2003 Jul 5;362(9377):14-21.
PMID: 12853194 [PubMed - indexed for MEDLINE] |
CIBIS
[No authors listed]
A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees.
Circulation. 1994 Oct;90(4):1765-73.
PMID: 7923660 [PubMed - indexed for MEDLINE] |
CIBIS II
No authors listed]
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.
Lancet. 1999 Jan 2;353(9146):9-13.
PMID: 10023943 [PubMed - indexed for MEDLINE] |
CIBIS III
Willenheimer R, Erdmann E, Follath F, Krum H, Ponikowski P, Silke B, Van Veldhuisen DJ, Van De Ven L, Verkenne P, Lechat P; CIBIS-III investigators.
Comparison of treatment initiation with bisoprolol vs. enalapril in chronic heart failure patients: rationale and design of CIBIS-III.
Eur J Heart Fail. 2004 Jun;6(4):493-500.
PMID: 15182776 [PubMed - indexed for MEDLINE] |
COMET
Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Hanrath P, Komajda M, Lubsen J, Lutiger B, Metra M, Remme WJ, Torp-Pedersen C, Scherhag A, Skene A;
Carvedilol Or Metoprolol European Trial Investigators.
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.
Lancet. 2003 Jul 5;362(9377):7-13.
PMID: 12853193 [PubMed - indexed for MEDLINE] |
COMPANION
Bristow MR, Feldman AM, Saxon LA.
Heart failure management using implantable devices for ventricular resynchronization: Comparison of Medical Therapy, Pacing, and Defibrillation in Chronic Heart Failure (COMPANION) trial. COMPANION Steering Committee and COMPANION Clinical Investigators.
J Card Fail. 2000 Sep;6(3):276-85.
PMID: 10997756 [PubMed - indexed for MEDLINE] |
COMPASS HF
Chronicle Offers Management to Patients With Advanced Signs and Symptoms of Heart Failure
Not yet published |
CONSENSUS
[No authors listed]
Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North CONSENSUS Trial Study Group.
N Engl J Med. 1987 Jun 4;316(23):1429-35.
PMID: 2883575 [PubMed - indexed for MEDLINE] |
COPERNICUS
Packer M, Fowler MB, Roecker EB, Coats AJ, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Staiger C, Holcslaw TL, Amann-Zalan I, DeMets DL;
Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group.
Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study.
Circulation. 2002 Oct 22;106(17):2194-9.
PMID: 12390947 [PubMed - indexed for MEDLINE] |
Cytokines and Cytokine Receptors in Advanced Heart Failure
Deswal A, Petersen NJ, Feldman AM, White BG, Mann DL.
Effects of vesnarinone on peripheral circulating levels of cytokines and cytokine receptors in patients with heart failure: a report from the Vesnarinone Trial.
Chest. 2001 Aug;120(2):453-9.
PMID: 11502643 [PubMed - indexed for MEDLINE] |
DAVID
Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H, Kutalek SP, Sharma A; Dual Chamber and VVI Implantable Defibrillator Trial Investigators.
Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
JAMA. 2002 Dec 25;288(24):3115-23.
PMID: 12495391 [PubMed - indexed for MEDLINE |
DEFINITE
Schaechter A, Kadish AH; DEFibrillators In Non-Ischemic CardiomyopathyTreatment Evaluation.
DEFibrillators In Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE).
Card Electrophysiol Rev. 2003 Dec;7(4):457-62.
PMID: 15071275 [PubMed - indexed for MEDLINE] |
DIAL
GESICA Investigators.
Randomised trial of telephone intervention in chronic heart failure: DIAL trial.
BMJ. 2005 Aug 20;331(7514):425.
PMID: 16061499 [PubMed - indexed for MEDLINE] |
DIAMOND-AF
Pedersen OD, Bagger H, Keller N, Marchant B, Kober L, Torp-Pedersen C.
Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy.
Circulation. 2001 Jul 17;104(3):292-6.
PMID: 11457747 [PubMed - indexed for MEDLINE] |
DIAMOND-CHF
[No authors listed]
Dofetilide in patients with left ventricular dysfunction and either heart failure or acute myocardial infarction: rationale, design, and patient characteristics of the DIAMOND studies. Danish Investigations of Arrhythmia and Mortality ON Dofetilide.
Clin Cardiol. 1997 Aug;20(8):704-10.
PMID: 9259163 [PubMed - indexed for MEDLINE] |
DIDI
Figulla HR, Gietzen F, Zeymer U, Raiber M, Hegselmann J, Soballa R, Hilgers R.
Diltiazem improves cardiac function and exercise capacity in patients with Idiopathic dilated cardiomyopathy. Results of the Diltiazem in Dilated Cardiomyopathy Trial.
Circulation. 1996 Aug 1;94(3):346-52.
PMID: 8759075 [PubMed - indexed for MEDLINE] |
DIG
Hobbs RE.
Digoxin's effect on mortality and hospitalization in heart failure: implications of the DIG study. Digitalis Investigation Group.
Cleve Clin J Med. 1997 May;64(5):234-7. No abstract available.
PMID: 9149472 [PubMed - indexed for MEDLINE] |
DIMP
van Veldhuisen DJ, Man in 't Veld AJ, Dunselman PH, Lok DJ, Dohmen HJ, Poortermans JC, Withagen AJ, Pasteuning WH, Brouwer J, Lie KI.
Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT).
J Am Coll Cardiol. 1993 Nov 15;22(6):1564-73.
PMID: 7901256 [PubMed - indexed for MEDLINE] |
EARTH
Anand I, McMurray J, Cohn JN, Konstam MA, Notter T, Quitzau K, Ruschitzka F, Luscher TF; EARTH investigators.
Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial.
Lancet. 2004 Jul 24-30;364(9431):347-54.
PMID: 15276394 [PubMed - indexed for MEDLINE] |
ELITE
Pitt B, Segal R, Martinez FA, Meurers G, Cowley AJ, Thomas I, Deedwania PC, Ney DE, Snavely DB, Chang PI.
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
Lancet. 1997 Mar 15;349(9054):747-52.
PMID: 9074572 [PubMed - indexed for MEDLINE] |
ELITE II
Pitt B, Poole-Wilson PA, Segal R, Martinez FA, Dickstein K, Camm AJ, Konstam MA, Riegger G, Klinger GH, Neaton J, Sharma D, Thiyagarajan B.
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.
Lancet. 2000 May 6;355(9215):1582-7.
PMID: 10821361 [PubMed - indexed for MEDLINE] |
ELVD-CHF
Giannuzzi P, Temporelli PL, Corra U, Tavazzi L; ELVD-CHF Study Group.
Antiremodeling effect of long-term exercise training in patients with stable chronic heart failure: results of the Exercise in Left Ventricular Dysfunction and Chronic Heart Failure (ELVD-CHF) Trial.
Circulation. 2003 Aug 5;108(5):554-9. Epub 2003 Jul 14.
PMID: 12860904 [PubMed - indexed for MEDLINE] |
EMIAT
Julian DG, Camm AJ, Frangin G, Janse MJ, Munoz A, Schwartz PJ, Simon P.
Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators.
Lancet. 1997 Mar 8;349(9053):667-74. Erratum in: Lancet 1997 Apr 19;349(9059):1180. Lancet 1997 Jun 14;349(9067):1776.
PMID: 9078197 [PubMed - indexed for MEDLINE] |
ENABLE
Kalra PR, Moon JC, Coats AJ.
Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure?
Int J Cardiol. 2002 Oct;85(2-3):195-7.
PMID: 12208583 [PubMed - indexed for MEDLINE] |
Enalapril: outcome of Patients with Congestive Heart Failure Treated with Standart vs. Hight dosis of enalapril
Nanas JN, Alexopoulos G, Anastasiou-Nana MI, Karidis K, Tirologos A, Zobolos S, Pirgakis V, Anthopoulos L, Sideris D, Stamatelopoulos SF, Moulopoulos SD.
Outcome of patients with congestive heart failure treated with standard versus high doses of enalapril: a multicenter study. High Enalapril Dose Study Group.
J Am Coll Cardiol. 2000 Dec;36(7):2090-5.
PMID: 11127445 [PubMed - indexed for MEDLINE] |
ENCOR
Enrasentan Cooperative Randomized Evaluation
Not yet published |
ENOXIMONE EXERCISE
Uretsky BF, Jessup M, Konstam MA, Dec GW, Leier CV, Benotti J, Murali S, Herrmann HC, Sandberg JA.
Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group.
Circulation. 1990 Sep;82(3):774-80.
PMID: 2144216 [PubMed - indexed for MEDLINE] |
ESCAPE
Binanay C, Califf RM, Hasselblad V, O'Connor CM, Shah MR, Sopko G, Stevenson LW, Francis GS, Leier CV, Miller LW; ESCAPE Investigators and ESCAPE Study Coordinators.
Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial.
JAMA. 2005 Oct 5;294(13):1625-33.
PMID: 16204662 [PubMed - indexed for MEDLINE] |
ESSENTIAL
The Studies of Oral Enoximone Therapy in Advanced Heart Failure
Not yet published |
FACET
Massie BM, Berk MR, Brozena SC, Elkayam U, Plehn JF, Kukin ML, Packer M, Murphy BE, Neuberg GW, Steingart RM, et al.
Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET).
Circulation. 1993 Aug;88(2):492-501.
PMID: 8339411 [PubMed - indexed for MEDLINE] |
FEST
Erhardt L, MacLean A, Ilgenfritz J, Gelperin K, Blumenthal M.
Fosinopril attenuates clinical deterioration and improves exercise tolerance in patients with heart failure. Fosinopril Efficacy/Safety Trial (FEST) Study Group.
Eur Heart J. 1995 Dec;16(12):1892-9.
PMID: 8682023 [PubMed - indexed for MEDLINE] |
FIRST
Califf RM, Adams KF, McKenna WJ, Gheorghiade M, Uretsky BF, McNulty SE, Darius H, Schulman K, Zannad F, Handberg-Thurmond E, Harrell FE Jr, Wheeler W, Soler-Soler J, Swedberg K.
A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST).
Am Heart J. 1997 Jul;134(1):44-54.
PMID: 9266782 [PubMed - indexed for MEDLINE] |
FUSION I
Yancy CW, Saltzberg MT, Berkowitz RL, Bertolet B, Vijayaraghavan K, Burnham K, Oren RM, Walker K, Horton DP, Silver MA.
Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting (from the FUSION I trial).
Am J Cardiol. 2004 Sep 1;94(5):595-601.
PMID: 15342289 [PubMed - indexed for MEDLINE] |
GESICA
Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R.
Randomised trial of low-dose amiodarone in severe congestive heart failure.
Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)
Lancet. 1994 Aug 20;344(8921):493-8.
PMID: 7914611 [PubMed - indexed for MEDLINE] |
HARDBALL
Heart Allograft Rejection: Detection with Breath Alkanes in Low Level
Not yet published |
HEART
Vaughan DE, Rouleau JL, Ridker PM, Arnold JM, Menapace FJ, Pfeffer MA.
Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. HEART Study Investigators.
Circulation. 1997 Jul 15;96(2):442-7.
PMID: 9244210 [PubMed - indexed for MEDLINE] |
HELAS
Cokkinos DV, Toutouzas PK.
Antithrombotic therapy in heart failure: a randomized comparison of warfarin vs. aspirin (HELAS).
Eur J Heart Fail. 1999 Dec;1(4):419-23.
PMID: 10937957 [PubMed - indexed for MEDLINE] |
Hy-C
Fonarow GC, Chelimsky-Fallick C, Stevenson LW, Luu M, Hamilton MA, Moriguchi JD, Tillisch JH, Walden JA, Albanese E.
Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trial.
J Am Coll Cardiol. 1992 Mar 15;19(4):842-50.
PMID: 1545080 [PubMed - indexed for MEDLINE] |
IMPACT-HF
Gattis WA, O'Connor CM, Gallup DS, Hasselblad V, Gheorghiade M; IMPACT-HF
Investigators and Coordinators.
Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial.
J Am Coll Cardiol. 2004 May 5;43(9):1534-41.
PMID: 15120808 [PubMed - indexed for MEDLINE] |
IMPRESS
Rouleau JL, Pfeffer MA, Stewart DJ, Isaac D, Sestier F, Kerut EK, Porter CB, Proulx G, Qian C, Block AJ.
Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomized trial.
Lancet. 2000 Aug 19;356(9230):615-20. Erratum in: Lancet 2000 Nov 18;356(9243):1774.
PMID: 10968433 [PubMed - indexed for MEDLINE] |
INSYNC
Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp RJ, Underwood J, Pickering F, Truex C, McAtee P, Messenger J; MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation.
Cardiac resynchronization in chronic heart failure.
N Engl J Med. 2002 Jun 13;346(24):1845-53.
PMID: 12063368 [PubMed - indexed for MEDLINE] |
INSYNC ICD
Abraham WT, Young JB, Leon AR, Adler S, Bank AJ, Hall SA, Lieberman R, Liem LB, O'Connell JB, Schroeder JS, Wheelan KR; Multicenter InSync ICD II Study Group.
Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.
Circulation. 2004 Nov 2;110(18):2864-8. Epub 2004 Oct 25.
PMID: 15505095 [PubMed - indexed for MEDLINE] |
Isosorbide Dinitrate Plus Low-Dose Furosemide vs Hight-Dose Furosemide Plus Low-Dose Isosorbide Dinitrate in Severe Pulmonary Edema
Cotter G, Metzkor E, Kaluski E, Faigenberg Z, Miller R, Simovitz A, Shaham O, Marghitay D, Koren M, Blatt A, Moshkovitz Y, Zaidenstein R, Golik A.
Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema.
Lancet. 1998 Feb 7;351(9100):389-93.
PMID: 9482291 [PubMed - indexed for MEDLINE] |
LIDO
Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, Harjola VP, Mitrovic V, Abdalla M, Sandell EP, Lehtonen L; Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study.
Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.
Lancet. 2002 Jul 20;360(9328):196-202.
PMID: 12133653 [PubMed - indexed for MEDLINE] |
M-ACE-INHITORS-IN-HF
McKelvie RS, Rouleau JL, White M, Afzal R, Young JB, Maggioni AP, Held P, Yusuf S.
Comparative impact of enalapril, candesartan or metoprolol alone or in combination on ventricular remodelling in patients with congestive heart failure.
Eur Heart J. 2003 Oct;24(19):1727-34.
PMID: 14522567 [PubMed - indexed for MEDLINE] |
MACH-1
Levine TB, Bernink PJ, Caspi A, Elkayam U, Geltman EM, Greenberg B, McKenna WJ, Ghali JK, Giles TD, Marmor A, Reisin LH, Ammon S, Lindberg E.
Effect of mibefradil, a T-type calcium channel blocker, on morbidity and mortality in moderate to severe congestive heart failure: the MACH-1 study. Mortality Assessment in Congestive Heart Failure Trial.
Circulation. 2000 Feb 22;101(7):758-64.
PMID: 10683349 [PubMed - indexed for MEDLINE] |
M-ARB-HF
Kasama S, Toyama T, Kumakura H, Takayama Y, Ichikawa S, Suzuki T, Kurabayashi M.
Effects of candesartan on cardiac sympathetic nerve activity in patients with congestive heart failure and preserved left ventricular ejection fraction.
J Am Coll Cardiol. 2005 Mar 1;45(5):661-7.
PMID: 15734608 [PubMed - indexed for MEDLINE] |
MDC
Waagstein F, Bristow MR, Swedberg K, Camerini F, Fowler MB, Silver MA, Gilbert EM, Johnson MR, Goss FG, Hjalmarson A.
Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group.
Lancet. 1993 Dec 11;342(8885):1441-6.
PMID: 7902479 [PubMed - indexed for MEDLINE] |
MERIT-HF
Hjalmarson A, Goldstein S, Fagerberg B, Wedel H, Waagstein F, Kjekshus J, Wikstrand J, El Allaf D, Vitovec J, Aldershvile J, Halinen M, Dietz R, Neuhaus KL, Janosi A, Thorgeirsson G, Dunselman PH, Gullestad L, Kuch J, Herlitz J, Rickenbacher P, Ball S, Gottlieb S, Deedwania P.
Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.
JAMA. 2000 Mar 8;283(10):1295-302.
PMID: 10714728 [PubMed - indexed for MEDLINE] |
Metoprolol/Carvedilol
Watanabe H, Kakihana M, Ohtsuka S, Sugishita Y.
Randomized, double-blind, placebo-controlled study of carvedilol on the prevention of nitrate tolerance in patients with chronic heart failure.
J Am Coll Cardiol. 1998 Nov;32(5):1194-200.
PMID: 9809925 [PubMed - indexed for MEDLINE] |
MEXIS
Persson H, Eriksson SV, Erhardt L.
Effects of beta receptor antagonists on left ventricular function in patients with clinical evidence of heart failure after myocardial infarction. A double-blind comparison of metoprolol and xamoterol. Echocardiographic results from the Metoprolol and Xamoterol Infarction Study (MEXIS).
Eur Heart J. 1996 May;17(5):741-9.
PMID: 8737105 [PubMed - indexed for MEDLINE] |
MHFT
Kleber FX, Niemoller L.
Long-term survival in the Munich Mild Heart Failure Trial (MHFT).
Am J Cardiol. 1993 May 15;71(13):1237-9. No abstract available.
PMID: 8480657 [PubMed - indexed for MEDLINE] |
MIRACLE
Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp RJ, Underwood J, Pickering F, Truex C, McAtee P, Messenger J; MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation.
Cardiac resynchronization in chronic heart failure.
N Engl J Med. 2002 Jun 13;346(24):1845-53.
PMID: 12063368 [PubMed - indexed for MEDLINE] |
MIRACLE ICD
Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, Canby RC, Schroeder JS, Liem LB, Hall S, Wheelan K; Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators.
Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.
JAMA. 2003 May 28;289(20):2685-94.
PMID: 12771115 [PubMed - indexed for MEDLINE] |
MOXCON
Cohn JN, Pfeffer MA, Rouleau J, Sharpe N, Swedberg K, Straub M, Wiltse C, Wright TJ; MOXCON Investigators.
Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON).
Eur J Heart Fail. 2003 Oct;5(5):659-67.
PMID: 14607206 [PubMed - indexed for MEDLINE] |
MUSTIC
Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, Garrigue S, Kappenberger L, Haywood GA, Santini M, Bailleul C, Daubert JC; Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators.
Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay.
N Engl J Med. 2001 Mar 22;344(12):873-80.
PMID: 11259720 [PubMed - indexed for MEDLINE] |
NETWORK
[No authors listed]
Clinical outcome with enalapril in symptomatic chronic heart failure; a dose comparison. The NETWORK Investigators.
Eur Heart J. 1998 Mar;19(3):481-9.
PMID: 9568453 [PubMed - indexed for MEDLINE] |
NICE
Lewis BS, Rabinowitz B, Schlesinger Z, Caspi A, Markiewicz W, Rosenfeld T, Sclarovsky S, Ermer W.
Effect of isosorbide-5-mononitrate on exercise performance and clinical status in patients with congestive heart failure. Results of the Nitrates in Congestive Heart Failure (NICE) Study.
Cardiology. 1999;91(1):1-7.
PMID: 10393392 [PubMed - indexed for MEDLINE] |
OPTIMAAL
Dickstein K, Kjekshus J; OPTIMAAL Steering Committee of the OPTIMAAL Study Group.
Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan.
Lancet. 2002 Sep 7;360(9335):752-60.
PMID: 12241832 [PubMed - indexed for MEDLINE] |
OPTIME-CHF
Felker GM, Benza RL, Chandler AB, Leimberger JD, Cuffe MS, Califf RM, Gheorghiade M, O'Connor CM; OPTIME-CHF Investigators.
Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study.
J Am Coll Cardiol. 2003 Mar 19;41(6):997-1003.
PMID: 12651048 [PubMed - indexed for MEDLINE] |
OVERTURE
Packer M, Califf RM, Konstam MA, Krum H, McMurray JJ, Rouleau JL, Swedberg K.
Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE).
Circulation. 2002 Aug 20;106(8):920-6.
PMID: 12186794 [PubMed - indexed for MEDLINE] |
PATH-CHF
Stellbrink C, Breithardt OA, Franke A, Sack S, Bakker P, Auricchio A, Pochet T, Salo R, Kramer A, Spinelli J; PATH-CHF (PAcing THerapies in Congestive Heart Failure) Investigators; CPI Guidant Congestive Heart Failure Research Group.
Impact of cardiac resynchronization therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbances.
J Am Coll Cardiol. 2001 Dec;38(7):1957-65.
PMID: 11738300 [PubMed - indexed for MEDLINE] |
PEECH
Prospective Evaluation of Enhanced External Counterpulsation in Congestive Heart Failure
Not published yet |
PEP-CHF
Cleland JG, Tendera M, Adamus J, Freemantle N, Gray CS, Lye M, O'Mahony D, Polonski L, Taylor J.
Perindopril for elderly people with chronic heart failure: the PEP-CHF study. The PEP investigators.
Eur J Heart Fail. 1999 Aug;1(3):211-7.
PMID: 10935667 [PubMed - indexed for MEDLINE] |
PRAISE
O'Connor CM, Carson PE, Miller AB, Pressler ML, Belkin RN, Neuberg GW, Frid DJ, Cropp AB, Anderson S, Wertheimer JH, DeMets DL.
Effect of amlodipine on mode of death among patients with advanced heart failure in the PRAISE trial. Prospective Randomized Amlodipine Survival Evaluation.
Am J Cardiol. 1998 Oct 1;82(7):881-7.
PMID: 9781971 [PubMed - indexed for MEDLINE] |
PRAISE 2
Cabell CH, Trichon BH, Velazquez EJ, Dumesnil JG, Anstrom KJ, Ryan T, Miller AB, Belkin RN, Cropp AB, O'Connor CM, Jollis JG.
Importance of echocardiography in patients with severe nonischemic heart failure: the second Prospective Randomized Amlodipine Survival Evaluation (PRAISE-2) echocardiographic study.
Am Heart J. 2004 Jan;147(1):151-7.
PMID: 14691434 [PubMed - indexed for MEDLINE] |
PRECISE
Packer M, Colucci WS, Sackner-Bernstein JD, Liang CS, Goldscher DA, Freeman I, Kukin ML, Kinhal V, Udelson JE, Klapholz M, Gottlieb SS, Pearle D, Cody RJ, Gregory JJ, Kantrowitz NE, LeJemtel TH, Young ST, Lukas MA, Shusterman NH.
Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise.
Circulation. 1996 Dec 1;94(11):2793-9.
PMID: 8941104 [PubMed - indexed for MEDLINE] |
PREMIER
Effects of PG-116800, a Matrix Metalloproteinase Inhibitor, to Prevent Left Ventricular Remodeling After Acute Myocardial Infarction
Not yet published |
PRIME II
Hampton JR, van Veldhuisen DJ, Kleber FX, Cowley AJ, Ardia A, Block P, Cortina A, Cserhalmi L, Follath F, Jensen G, Kayanakis J, Lie KI, Mancia G, Skene AM.
Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Second Prospective Randomised Study of Ibopamine on Mortality and Efficacy (PRIME II) Investigators.
Lancet. 1997 Apr 5;349(9057):971-7.
PMID: 9100622 [PubMed - indexed for MEDLINE] |
PROFILE
Hansen MS, Stanton EB, Gawad Y, Packer M, Pitt B, Swedberg K, Rouleau JL; Canadian PROFILE investigators.
Relation of circulating cardiac myosin light chain 1 isoform in stable severe congestive heart failure to survival and treatment with flosequinan.
Am J Cardiol. 2002 Nov 1;90(9):969-73.
PMID: 12398964 [PubMed - indexed for MEDLINE] |
PROMISE
Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, Hendrix GH, Bommer WJ, Elkayam U, Kukin ML, et al.
Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.
N Engl J Med. 1991 Nov 21;325(21):1468-75.
PMID: 1944425 [PubMed - indexed for MEDLINE] |
PROVED
Uretsky BF, Young JB, Shahidi FE, Yellen LG, Harrison MC, Jolly MK.
Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group.
J Am Coll Cardiol. 1993 Oct;22(4):955-62.
PMID: 8409069 [PubMed - indexed for MEDLINE] |
RADIANCE
Packer M, Gheorghiade M, Young JB, Costantini PJ, Adams KF, Cody RJ, Smith LK, Van Voorhees L, Gourley LA, Jolly MK.
Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study.
N Engl J Med. 1993 Jul 1;329(1):1-7.
PMID: 8505940 [PubMed - indexed for MEDLINE] |
RALES
Kulbertus H.
[Study of the month. The RALES study (randomized aldactone evaluation study]
Rev Med Liege. 1999 Sep;54(9):770-2. French.
PMID: 10589274 [PubMed - indexed for MEDLINE] |
REDHOT
Maisel A, Hollander JE, Guss D, McCullough P, Nowak R, Green G, Saltzberg M, Ellison SR, Bhalla MA, Bhalla V, Clopton P, Jesse R; Rapid Emergency Department Heart Failure Outpatient Trial investigators.
Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath.
J Am Coll Cardiol. 2004 Sep 15;44(6):1328-33.
PMID: 15364340 [PubMed - indexed for MEDLINE] |
REFLECT
Packer M, Narahara KA, Elkayam U, Sullivan JM, Pearle DL, Massie BM, Creager
MA.
Double-blind, placebo-controlled study of the efficacy of flosequinan in patients with chronic heart failure. Principal Investigators of the REFLECT Study.
J Am Coll Cardiol. 1993 Jul;22(1):65-72.
PMID: 8509565 [PubMed - indexed for MEDLINE] |
REMATCH
Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL; Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group.
Long-term mechanical left ventricular assistance for end-stage heart failure.
N Engl J Med. 2001 Nov 15;345(20):1435-43. Summary for patients in: J Card Fail.
2002 Apr;8(2):59-60. J Card Fail. 2002 Apr;8(2):61-2.
PMID: 11794191 [PubMed - indexed for MEDLINE] |
RENEWAL
Mann DL, McMurray JJ, Packer M, Swedberg K, Borer JS, Colucci WS, Djian J, Drexler H, Feldman A, Kober L, Krum H, Liu P, Nieminen M, Tavazzi L, van Veldhuisen DJ, Waldenstrom A, Warren M, Westheim A, Zannad F, Fleming T.
Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).
Circulation. 2004 Apr 6;109(13):1594-602. Epub 2004 Mar 15.
PMID: 15023878 [PubMed - indexed for MEDLINE] |
RESOLVD
McKelvie RS, Yusuf S, Pericak D, Avezum A, Burns RJ, Probstfield J, Tsuyuki RT, White M, Rouleau J, Latini R, Maggioni A, Young J, Pogue J.
Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators.
Circulation. 1999 Sep 7;100(10):1056-64.
PMID: 10477530 [PubMed - indexed for MEDLINE] |
REVASC
Vascular endothelial growth factor (VEGF)
Not yet published |
REVIVE II
Inotropic agents
Not yet published |
RITZ 4
O'Connor CM, Gattis WA, Adams KF Jr, Hasselblad V, Chandler B, Frey A, Kobrin I, Rainisio M, Shah MR, Teerlink J, Gheorghiade M; Randomized Intravenous TeZosentan Study-4 Investigators.
Tezosentan in patients with acute heart failure and acute coronary syndromes:
results of the Randomized Intravenous TeZosentan Study (RITZ-4).
J Am Coll Cardiol. 2003 May 7;41(9):1452-7.
PMID: 12742280 [PubMed - indexed for MEDLINE] |
RITZ 5
Kaluski E, Kobrin I, Zimlichman R, Marmor A, Krakov O, Milo O, Frey A, Kaplan S, Krakover R, Caspi A, Vered Z, Cotter G.
RITZ-5: randomized intravenous TeZosentan (an endothelin-A/B antagonist) for the treatment of pulmonary edema: a prospective, multicenter, double-blind, placebo-controlled study.
J Am Coll Cardiol. 2003 Jan 15;41(2):204-10.
PMID: 12535809 [PubMed - indexed for MEDLINE] |
RUSSLAN
Moiseyev VS, Poder P, Andrejevs N, Ruda MY, Golikov AP, Lazebnik LB, Kobalava ZD, Lehtonen LA, Laine T, Nieminen MS, Lie KI; RUSSLAN Study Investigators.
Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN).
Eur Heart J. 2002 Sep;23(18):1422-32.
PMID: 12208222 [PubMed - indexed for MEDLINE] |
SCD HeFT
Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M,Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators.
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
N Engl J Med. 2005 Jan 20;352(3):225-37. Erratum in: N Engl J Med. 2005 May
19;352(20):2146.
PMID: 15659722 [PubMed - indexed for MEDLINE] |
SENIORS
Study of effects of nebivolol intervention on outcomes and rehospitalisation in seniors with heart failure
Not yet published |
SIRIUS-2
Safety and Efficacy of an Intravenous Placebo-Controlled Randomized Infusion of Ularitide
Not yet published |
SOLV Prevention
[No authors listed]
Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigattors.
N Engl J Med. 1992 Sep 3;327(10):685-91. Erratum in: N Engl J Med 1992 Dec 10;327(24):1768.
PMID: 1463530 [PubMed - indexed for MEDLINE] |
SPAN-CHF
Kimmelstiel C, Levine D, Perry K, Patel AR, Sadaniantz A, Gorham N, Cunnie M, Duggan L, Cotter L, Shea-Albright P, Poppas A, LaBresh K, Forman D, Brill D, Rand W, Gregory D, Udelson JE, Lorell B, Konstam V, Furlong K, Konstam MA.
Randomized, controlled evaluation of short- and long-term benefits of heart failure disease management within a diverse provider network: the SPAN-CHF trial.
Circulation. 2004 Sep 14;110(11):1450-5. Epub 2004 Aug 16.
PMID: 15313938 [PubMed - indexed for MEDLINE] |
STICH
Surgical Treatments for Ischemic Heart Failure
Not yet published |
SURVIVE-W
Survival of Patients with Acute Heart Failure in Need of Intravenous Inotropic Support
Not yet published |
SWORD
Waldo AL, Camm AJ, deRuyter H, Friedman PL, MacNeil DJ, Pauls JF, Pitt B, Pratt CM, Schwartz PJ, Veltri EP.
Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol.
Lancet. 1996 Jul 6;348(9019):7-12. Erratum in: Lancet 1996 Aug 10;348(9024):416.
PMID: 8691967 [PubMed - indexed for MEDLINE] |
TEN-HMS
Cleland JG, Louis AA, Rigby AS, Janssens U, Balk AH; TEN-HMS Investigators.
Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study.
J Am Coll Cardiol. 2005 May 17;45(10):1654-64. Epub 2005 Apr 22.
PMID: 15893183 [PubMed - indexed for MEDLINE] |
TRACE
Kober L, Torp-Pedersen C, Carlsen JE, Bagger H, Eliasen P, Lyngborg K, Videbaek J, Cole DS, Auclert L, Pauly NC.
A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.
N Engl J Med. 1995 Dec 21;333(25):1670-6.
PMID: 7477219 [PubMed - indexed for MEDLINE] |
TWA in CHF
T Wave Alternans in Congestive Heart Failure
Not yet published |
US-CARVEDILOL-TRIAL
Colucci WS, Packer M, Bristow MR, Gilbert EM, Cohn JN, Fowler MB, Krueger SK, Hershberger R, Uretsky BF, Bowers JA, Sackner-Bernstein JD, Young ST, Holcslaw TL, Lukas MA.
Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group.
Circulation. 1996 Dec 1;94(11):2800-6.
PMID: 8941105 [PubMed - indexed for MEDLINE] |
VAL-HEFT
Cohn JN, Tognoni G; Valsartan Heart Failure Trial Investigators.
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
N Engl J Med. 2001 Dec 6;345(23):1667-75. Summary for patients in: J Card Fail. 2002 Apr;8(2):56-8.
PMID: 11759645 [PubMed - indexed for MEDLINE] |
VALIANT
Velazquez EJ, Pfeffer MA, McMurray JV, Maggioni AP, Rouleau JL, Van de Werf F, Kober L, White HD, Swedberg K, Leimberger JD, Gallo P, Sellers MA, Edwards S, Henis M, Califf RM; VALIANT Investigators.
VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context.
Eur J Heart Fail. 2003 Aug;5(4):537-44.
PMID: 12921816 [PubMed - indexed for MEDLINE] |
Vasopresin V2-Receptor Blockade with Tolvaptan in Patiens with CHF
Gheorghiade M, Niazi I, Ouyang J, Czerwiec F, Kambayashi J, Zampino M, Orlandi C; Tolvaptan Investigators.
Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial.
Circulation. 2003 Jun 3;107(21):2690-6. Epub 2003 May 12.
PMID: 12742979 [PubMed - indexed for MEDLINE] |
VERBS
Pachon JC, Pachon EI, Albornoz RN, Pachon JC, Kormann DS, Gimenes VM, Medeiros PT, Silva MA, Sousa JE, Paulista PP, Souza LC, Jatene AD.
Ventricular endocardial right bifocal stimulation in the treatment of severe dilated cardiomyopathy heart failure with wide QRS.
Pacing Clin Electrophysiol. 2001 Sep;24(9 Pt 1):1369-76.
PMID: 11584459 [PubMed - indexed for MEDLINE] |
VERITAS
Value of Endothelin Receptor Inhibition With Tezosentan in Acute Heart Failure Studies
Not yet published |
Vesnarinone
Feldman AM, Bristow MR, Parmley WW, Carson PE, Pepine CJ, Gilbert EM, Strobeck JE, Hendrix Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group.
N Engl J Med. 1993 Jul 15;329(3):149-55.
PMID: 8515787 [PubMed - indexed for MEDLINE] |
V-HEFT I
Cohn JN.
Effect of vasodilator therapy on mortality in chronic congestive heart failure.
Eur Heart J. 1988 Jan;9 Suppl A:171-3.
PMID: 3044793 [PubMed - indexed for MEDLINE] |
V-HEFT II
Ziesche S, Cobb FR, Cohn JN, Johnson G, Tristani F.
Hydralazine and isosorbide dinitrate combination improves exercise tolerance in heart failure. Results from V-HeFT I and V-HeFT II. The V-HeFT VA Cooperative Studies Group.
Circulation. 1993 Jun;87(6 Suppl):VI56-64.
PMID: 8500241 [PubMed - indexed for MEDLINE] |
V-HEFT III
Cohn JN, Ziesche S, Smith R, Anand I, Dunkman WB, Loeb H, Cintron G, Boden W, Baruch L, Rochin P, Loss L.
Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study Group.
Circulation. 1997 Aug 5;96(3):856-63.
PMID: 9264493 [PubMed - indexed for MEDLINE] |
VIGOR Echo Substudy
Saxon LA, De Marco T, Schafer J, Chatterjee K, Kumar UN, Foster E; VIGOR Congestive Heart Failure Investigators.
Effects of long-term biventricular stimulation for resynchronization on echocardiographic measures of remodeling.
Circulation. 2002 Mar 19;105(11):1304-10.
PMID: 11901040 [PubMed - indexed for MEDLINE] |
VMAC
Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF).
Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
JAMA. 2002 Mar 27;287(12):1531-40. Erratum in: JAMA 2002 Aug 7;288(5):577.
PMID: 11911755 [PubMed - indexed for MEDLINE] |
WASH
Cleland JG, Findlay I, Jafri S, Sutton G, Falk R, Bulpitt C, Prentice C, Ford I, Trainer A, Poole-Wilson PA.
The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure.
Am Heart J. 2004 Jul;148(1):157-64.
PMID: 15215806 [PubMed - indexed for MEDLINE] |
WATCH
Warfarin and Antiplatelet Trial in Chronic Heart Failure
Not yet published |
Xamoterol Heart Failure
[No authors listed]
Xamoterol in severe heart failure. The Xamoterol in Severe Heart Failure Study Group.
Lancet. 1990 Jul 7;336(8706):1-6. Erratum in: Lancet 1990 Sep 15;336(8716):698.
PMID: 1694945 [PubMed - indexed for MEDLINE] |
|
